SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-165926
Filing Date
2017-05-10
Accepted
2017-05-10 16:23:56
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d373714d10q.htm 10-Q 340139
2 CERTIFICATION d373714dex311.htm EX-31.1 10338
3 CERTIFICATION d373714dex312.htm EX-31.2 10323
4 CERTIFICATION d373714dex321.htm EX-32.1 4291
5 CERTIFICATION d373714dex322.htm EX-32.2 4265
  Complete submission text file 0001193125-17-165926.txt   2486151

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20170331.xml EX-101.INS 399320
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20170331.xsd EX-101.SCH 37693
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20170331_cal.xml EX-101.CAL 45423
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20170331_def.xml EX-101.DEF 112204
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20170331_lab.xml EX-101.LAB 276955
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20170331_pre.xml EX-101.PRE 195593
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 17830613
SIC: 2834 Pharmaceutical Preparations